Hinge Health (HNGE) Stock News

Hinge Health (NYSE:HNGE) has launched HingeSelect, a high-performance provider network for musculoskeletal (MSK) care that combines AI-powered digital exercise therapy with access to in-person care providers at up to 50% below PPO rates. The platform features unified care delivery, where technology and in-house orthopedic physicians triage patients and direct them to appropriate evidence-based treatments. Members can access orthopedic specialists within 48 hours and schedule in-person appointments directly through the app. HingeSelect addresses key healthcare challenges including long appointment wait times (averaging 20 days), variable adherence to evidence-based care among providers, and high costs. The platform offers a curated network of local physical therapists, imaging centers, and physicians, with bundled pricing for transparent, predictable costs and reduced member cost sharing.

Hinge Health (NYSE: HNGE) announced significant cost savings from a medical claims analysis, showing $2,343 average savings per member annually and a 2.4x ROI for fully insured health plan members using its digital musculoskeletal (MSK) platform. The study, validated by Gallagher, analyzed 4,788 health plan members and revealed reduced healthcare service utilization, with 44% of claims reductions attributed to avoided surgeries. The analysis compared Hinge Health participants with a matched control group using a claims database of over 100 million commercially insured lives from 2017 to 2023. The results reinforce previous studies demonstrating consistent 2x+ ROI across various demographics, including multi-employer and Medicare populations.

Hinge Health (NYSE: HNGE) has announced the pricing of its Initial Public Offering (IPO), offering 13,666,000 shares of Class A common stock at $32.00 per share. The offering consists of 8,522,528 shares from Hinge Health and 5,143,472 shares from selling stockholders. Trading is set to begin on the NYSE on May 22, 2025, under the ticker "HNGE".

The selling stockholders have granted underwriters a 30-day option to purchase up to 2,049,900 additional shares. The company plans to use the proceeds primarily to cover tax obligations related to restricted stock units. Morgan Stanley, Barclays, and BofA Securities are serving as lead book-running managers for the offering.